Published in Virus Weekly, March 27th, 2001
M. Niedrig and colleagues set out to compare EIA specificity for tick-borne encephalitis virus (TBEV), a human flavivirus endemic in some parts of Europe and Asia. The EIAs typically are used to test for presence of the disease or the success of vaccination.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.